ArticleResearch (Washington, D.C.)2022

Targeting the LSD1-G9a-ER Stress Pathway as a Novel Therapeutic Strategy for Esophageal Squamous Cell Carcinoma.

Hongxiao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.